Yüklüyor......
Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide
[Image: see text] Chidamide is a histone deacetylase (HDAC) inhibitor that is currently used to treat cutaneous T-cell lymphoma in clinic. Herein nicotinamide phosphoribosyltransferase (NAMPT) was identified to be a new target of chidamide on the basis of the pharmacophore analysis, molecular dockin...
Kaydedildi:
| Yayımlandı: | ACS Med Chem Lett |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American
Chemical
Society
2019
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956351/ https://ncbi.nlm.nih.gov/pubmed/31938461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.9b00407 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|